Alopecia Areata of the Beard: A Review of the Literature

被引:20
作者
Cervantes, Jessica [1 ]
Fertig, Raymond M. [1 ]
Maddy, Austin [1 ]
Tosti, Antonella [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, 1475 NW 12th Ave, Miami, FL 33136 USA
关键词
TRIAMCINOLONE ACETONIDE; TOPICAL MINOXIDIL; HAIR-GROWTH; THERAPY; EPIDEMIOLOGY; ASSOCIATION; DIAGNOSIS; UPDATE; LAMP;
D O I
10.1007/s40257-017-0297-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Alopecia areata (AA) is a T-cell mediated autoimmune disorder in which inflammatory cells attack the hair follicle, resulting in round, well-circumscribed patches of noncicatricial hair loss in normal appearing skin. AA affecting the beard area is well known and is referred to as AA of the beard (BAA) or AA barbae when involvement is limited exclusively to the beard. BAA has been documented in a select number of studies. We review the literature and discuss the clinical features, epidemiology, diagnosis, and treatment of BAA. Clinical presentation of BAA can vary and manifest as single small areas of hair loss, multiple small or large simultaneous focuses, or total hair loss. Most patients are middle-aged males with focal patches of round or oval hair loss, mostly localized along the jawline. Patches are characteristically well circumscribed and smooth with white hair present at the periphery. Dermoscopic features of BAA include yellow dots, broken hair, and short vellus hairs. BAA may be associated with other autoimmune disorders, including atopic dermatitis, vitiligo, and psoriasis. Many treatment modalities are available for BAA, and selection of a therapy depends on several factors, including disease activity, extent of area affected, duration of disease, and age of the patient. Topical corticosteroids are most commonly used as initial treatment, followed by intralesional steroids. Other therapeutic modalities are discussed.
引用
收藏
页码:789 / 796
页数:8
相关论文
共 38 条
  • [1] 308-nm excimer laser for the treatment of alopecia areata
    Al-Mutairi, Nawaf
    [J]. DERMATOLOGIC SURGERY, 2007, 33 (12) : 1483 - 1487
  • [2] Alopecia areata update Part II. Treatment
    Alkhalifah, Abdullah
    Alsantali, Adel
    Wang, Eddy
    McElwee, Kevin J.
    Shapiro, Jerry
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (02) : 191 - 202
  • [3] Narrowband ultraviolet B phototherapy for alopecia areata
    Bayramgurler, Dilek
    Demirsoy, Evren Odyakmaz
    Akturk, Aysun Sikar
    Kiran, Rebiay
    [J]. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2011, 27 (06) : 325 - 327
  • [4] BURTON JL, 1975, ACTA DERM-VENEREOL, V55, P493
  • [5] Cure of alopecia areata after eradication of Helicobacter pylori: A new association?
    Campuzano-Maya, German
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (26) : 3165 - 3170
  • [6] Alopecia areata: What's new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
    Dainichi, Teruki
    Kabashima, Kenji
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 86 (01) : 3 - 12
  • [7] Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): Results of an open-label, paired-comparison, clinical trial
    Dall'Oglio, F
    Nasca, MR
    Musumeci, ML
    La Torre, G
    Ricciardi, G
    Potenza, C
    Micali, G
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (01) : 10 - 14
  • [8] DAWBER R., 1997, DIS HAIR SCALP
  • [9] Eckert MM, 2016, J Cosmetology Trichology, V2, DOI [10.4172/2471-9323.1000108, DOI 10.4172/2471-9323.1000108]
  • [10] Emre S, 2016, CUTIS, V97, pE30